323. Martin G. The effect of food odour on the human brain // Proc. Brit Psychol Soc. – 1997. – V. 5. – № 1. – P. 57.
324. Martin M., Schelling H. R. Demenz in Schlusselbegriffen. – Bern: Verlag Hans Huber, 2005. – 283 p.
325. Maurer K., Volk S., Gerbaldo H. Auguste D and Alzheimers disease // Lancet. – 1997. – V. 349. – № 9064. – P. 1546–1549.
326. Meyer J. H., Ginovart N., Boovariwala A. et al. Elevated monoamine oxidase A levels in the brain // Arch Gen Psychiatry. – 2006. – V. 63. – № 6. – P. 1209–1216.
327. Meyer T W, Hostetter T. H. Uremia // N Ehgl J Med. – 2007. – V. 357. – P. 1316–1325.
328. Miller D. H., Leary S. M. Primary-progressive multiple sclerosis // Lancet Neurology. – 2007. – V. 6. – № 10. – P. 903–912.
329. Miyoshi N., Kazui H., Ogino A. et al. Association between cognitive impairment and gait disturbance in patients with INPH // Dement Geriatr Cogn Disord. – 2005. – V. 20. – № 1. – P. 71–76.
330. Mogilnaya V. I., Litvinenko I. V., Sologub O. S. Hyperhomocysteinemia in Parkinson’s disease // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 55.
331. Mosley R. L., Benner E. J., Kadiu I. et al. Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson’s Disease // Clin Neurosci Res. – 2006. – № 5. – P. 281.
332. Naarding P., de Koning I., dan Kooten F. et al. Depression in vascular dementia // Int. J. Geriatr. Psychiatry. – 2003. – V. 18. – № 2. – P. 325–330.
333. Neary D., Snowden J. S., Gustafson I. et al. Frontotemporal lobar degeneration // Neurology. – 1998. – V. 51. – № 6. – P. 1546–1554.
334. Nosarti C., Giouroukou E., Micali N. et al. Impaired executive functioning in young adults born very preterm // J. Int. Neuropsychol. Soc. – 2007. – V. 13. – № 4. – P. 571–581.
335. Orgogozo J. M., Gaichies S., Dartigues J. F. Influence of behavioural symptoms on resourse use // Neurodegenerative Dis.4 (Suppl 1). – 2007. – P. 51.
336. Ott A., Stolk R. P., van Harskamp F. et al. Diabetes mellitus and the risk of dementia // Neurology. – 1999. – V. 53. – № 10. – P. 1937–1942.
337. Pacher P., Beckman J. S., Liaudet L. Nitric Oxide and Peroxynitrite in Health and Disease // Physiol Rev. – 2007. – V. 87. – № 1. – P. 315–424.
338. Paraskevas K. I., Mikhailidis D. P., Liapis C. D. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors // Angiology. – 2007. – V. 58. – № 3. – P. 329–335.
339. Park K. W., Roh J. H., Koh S. B., Lee D. H. The characteristics of cognitive impairment in Parkinson disease // Neurodegenerative Dis.4 (Suppl 1). – 2007. – P. 291.
340. Parkinsons disease: genetics and pathogenesis. ed. T. M. Dawson. In-forma Healthcare. – 2007. – USS24995. – 392 p.
341. Pelliccia A., Di Paolo F. M., Quattrini F.M. et al. Outcomes in athletes with marked ECG repolarization abnormalities // N. Engl. J. Med. – 2008. – V. 358. – № 2. – P. 152–161.
342. Petersen R. C., Doody R., Kurz A. et al. Current concepts in mild cognitive impairment // Arch. Neurol. – 2001. – V. 58. – № 9. – P. 1985–1992.
343. Petersen R. C., Touchon J. Consensus on mild cognitive impairment // Research and Practice in Alzheimers disease. Joint Meeting. Serdi Publisher. Paris. – 2005. – V. 10. – № 1. – P. 24–32.
344. Pfefferbaum A., Rosenbloom M. J., Adalsteinsson E., Sullivan E.V. Diffusion tensor imaging with quantitative fibre tracking in HIV infection and alcoholism comorbidity // Brain. – 2007. – V. 130. – Part 1. – P. 8–64.
345. Philbin M., Klaas P. Hearing and behavioral responses to sound in fullterm newborns // J Perinatol. – 2000. – V. 20. – № 12. – P. 68–76.
346. Phukan J., Pender N. P., Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis // Lancet Neurology. – 2007. – V. 6. – № 11. – P. 994–1003.
347. Prechtl H. F. R. The optimality concept // Early human development. – 1980. – V. 4–3. – № 2. – P. 201–205.
348. Prechtl H. F. R., Cioni G., Einspieler C. et al. Role of vision on early motor development // Development medicine and child neurology. – 2001. – V. 43. – № 1. – P. 198–201.
349. Radunovic A., Mitsumoto H., Leigh. Clinical care of patients with amyotrophic lateral sclerosis // Lancet. Neurology. – 2007. – V. 6. – № 10. – P. 913–925.
350. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells // Biol Psychiatry. – 2000. – V. 48. – № 4. – P. 766–777.
251. Ranganathan S., Williams E., Ganchev P. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis // J. Neurochem. – 2005. – V. 95. – № 5. – P. 1461–1471.
352. Raskind M. A., Peskind E. R., Wessel T. Galantamine in AD // Neurology. – 2000. – V. 54. – № 12. – P. 2261–2268.
353. Reisberg B. Functional assessment staging (FAST) // Psychopharmacol bulletin. – 1988. – V. 24. – № 4. – P. 653–659.
354. Reisberg B., Franssen E. H., Souren L. E. et al. Evidence and mechanisms of retrogenesis in Alzheimers and other dementias // Am J of Alzheimers disease and other dementias. – 2002. – V. 17. – № 4. – P. 202–212.
355. Riederer P. F., Tribl F., Grunblatt E. The early detection in Parkinson’s disease // Neurodegenerative Dis. 4 (Suppl 1). – 2007. – P. 110–111.
356. Rockwood K., Mintzer J., Truyen L. et al. Effects of a flexible galantamine dose in Alzheimers disease: a randomised, controlled trial // J. Neurol Neurosurg Psychiatry. – 2001. – V. 71. – № 4. – P. 589–595.
357. Rogers H., Carlos J., Lasprilla C.A. Retrogenesis theory in Alzheimers disease // Anales de psycologia. – 2006. – V. 22. – № 2. – P. 260–266.
358. Roman G. C. Diagnostic criterions of vascular dementia // Neurology. – 1993. – V. 43. № 1. – P. 250–256.
359. Roman G. C. Vascular dementia prevention: a risk factor analysis // Cerebrovasc Dis. – 2005. – Vol. 20 (Suppl 2). – P. 91–100.
360. Ryan R. M., Kuhl J., Deci E. L. Nature and autonomy // Devel. and Psychopathol. – 1997. – № 9. – P. 701–728.
361. Saffran J. R., Loman M. M., Robertson R. R. Infant long-term memory for music. – Ann NY Acad Sci, 2001. – V. 930. – № 6. – P. 397–400.
362. Saha S., Hsu C., Ferree A. et al. Genes associated with familial Parkinsons disease // Neurodegenerative Dis. 4 (Suppl 1). – 2007. – P. 15.
363. Sanai N., Mirzadeh, Berger M. S. Functional outcome after language mapping for glioma resection // N. Engl. J. Med. – 2008. – V. 358. – № 2. – P. 107–110.
